No Data
No Data
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges
China SXT Pharmaceuticals Optimizes Capital Structure With Warrant Exchange
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Express News | China SXT Pharmaceuticals Regained Nasdaq Compliance
China SXT Pharmaceuticals Has Regained Compliance With Nasdaq's Minimum Bid Price Deficiency